Roland Baron, Harvard School of Dental Medicine (Boston, USA)
Dr. Roland Baron is Professor at the Harvard Medical School, Endocrine Unit, Massachusetts General Hospital, and Chair of Oral Medicine at the Harvard School of Dental Medicine from January 2008. From 1977- 2007 Dr Roland Baron was a Professor in the departments of Orthopedics and Cell Biology at Yale University School of Medicine. He received his DDS and PhD degrees from the University of Paris, France. He is the founder and current Editor-in-Chief of BONE. Between 1994 and 2002, he also held the position of Vice President and Head of the Bone Diseases Group at Hoechst Marion Roussel and then Aventis. In 2002 he founded ProSkelia, a small pharmaceutical company devoted to the discovery and development of new drugs for bone and hormonal dependent diseases. He has held the positions of President and Chief Scientific Officer of ProSkelia and then ProStrakan, until April 2006. Dr Baron has published over 300 scientific papers in the field of bone biology and bone diseases.
Michaela Kneissel is Global Head of the Musculoskeletal Disease Area at the Novartis Institutes for BioMedical Research. Michaela Kneissel received her Ph.D. from the University of Vienna, Austria. She performed part of her Ph.D. work at the Hard Tissue Research Unit, University College London, UK and was postdoctoral fellow at the Radiobiology Division, University of Utah, Salt Lake City, USA before joining Novartis in 1996 where she has held several positions of increasing responsibility. Michaela Kneissel currently serves on the board of directors of the International Society for Bone Morphometry and on the editorial board of Calcified Tissue International and BONE.
Dr. Lee is the Robert and Janice McNair Endowed Chair in Molecular and Human Genetics, Professor in the Department of Molecular and Human Genetics at Baylor College of Medicine and an Investigator of the Howard Hughes Medical Institute. Dr. Lee co-directs the joint MD Anderson Cancer Center and Baylor College of Medicine Rolanette and Berdon Lawrence Bone Disease Program of Texas and directs the Baylor College of Medicine Center for Skeletal Medicine and Biology. He is Founder and Director of the Skeletal Dysplasia Clinic at Texas Children’s Hospital. As a pediatrician and geneticist, Dr. Lee studies structural birth defects and inborn errors of metabolism. Dr. Lee identified the first genetic causes of human skeletal dysplasias. Most recently, he discovered new causes of brittle bone disease in children and adults and how these disorders reflect alter matrix-cell signaling in the skeleton. In so doing, he is developing new approaches for diagnosing and treating these disorders. His program ranges from mouse mechanistic studies informed by human genetic discoveries to clinical interventional trials.
Henry M. Kronenberg is Chief of the Endocrine Unit at the Massachusetts General Hospital and Professor of Medicine at the Harvard Medical School. There he leads a research group that studies the actions of parathyroid hormone and parathyroid hormone-related protein, with a particular emphasis on bone development, bone biology, calcium homeostasis, and the roles of osteoblast-lineage cells in hematopoiesis. Dr. Kronenberg’s laboratory in recent years has used a number of genetically altered strains of mice to establish the role of signaling by the PTH/PTHrP receptor in bone.
Dr. Kronenberg received his BA from Harvard University, his MD from Columbia University, his medical house officer training at the Massachusetts General Hospital, and post-doctoral training at NIH, MIT, and the MGH. He has served as President of the American Society for Bone and Mineral Research and of the International Bone and Mineral Society.. He has won the Fuller Albright Young Investigator Award, the William F. Neuman Award, and the Rodan Mentoring Award of the American Society for Bone and Mineral Research, the Copp Award of the International Bone and Mineral Society, and the Gerald D. Aurbach Lecture Award of the Endocrine Society.
Cliff Rosen is studying mesenchymal stem cell fate with particular reference to the switch between pre-adipocytes and pre-osteoblasts and how that relates to marrow adiposity. There are currently four NIH funded projects in this laboratory, all center on a central theme of lineage allocation and its alterations in osteoporosis. Dr. Rosen is also the Director of the Physiology Core of the MMCRI COBRE and oversees whole body and cell phenotyping related to metabolic function. The laboratory has also recently been interested in cold induced thermogenesis and its effect on the skeleton as well as mitochondrial function in osteoblasts using newer Seahorse Biosciences technology. Dr. Rosen completed his term as an Associate Editor of the Journal of Clinical Endocrinology and Metabolism and continues to be an editor at Aging Cell. He was recently appointed as senior associate editor at the Journal of Bone and Mineral Research. He has served for 13 years as an external advisor for the P30 Yale Musculoskeletal Core which has been renewed successfully three times. He completed membership on the NIH NIAMS Advisory Council, is a standing member of the FDA Endocrinologic and Metabolic Diseases Advisory Committee, and was a senior committee person for the Institute of Medicine on dietary calcium and vitamin D and the IOM Committee on clinical and translational research. Dr. Rosen has had the unique honor of serving as chair of both a basic NIH peer review study section (Skeletal Biology Disease and Development) and the NIH Clinical Trials Study Section (AMSCT). He currently is on the executive committee for the NIH funded D2d randomized clinical trial of vitamin D for the prevention of type 2 diabetes.
Jo Price qualified as a veterinary surgeon from Bristol University then spent a number of years in clinical practice before studying for a PhD with Graham Russell on the biology of deer antler regeneration. After two years working as a post-doctoral fellow on bone’s adaptation to mechanical loading in Lance Lanyon’s laboratory at the Royal Veterinary College (RVC), she continued with her research on antler regeneration under the mentorship of Mike Horton at University College London. She returned to the RVC in 2000 and then was appointed Professor of Veterinary Anatomy and Head of Department in 2005, and in 2009 was appointed Head of Bristol Veterinary School. Her current research focuses on mechanically-related functional adaptation in bone, in particular interactions between estrogen receptors and other signaling pathways and the effects of ageing on the mechanostat. Osteocyte biology is therefore a specific research interest. Another long-standing research interest has been the pathogenesis and prevention of musculoskeletal injuries in horses.
Workshop attendance is limited to 150 attendees. Participants are strongly encouraged to submit abstracts that showcase unpublished data, to foster discussion and constructive feedback in ample poster, oral, and clustered discussion sessions. Oral presentations will be selected from the abstracts.
All are welcome as participants, with priority in programming given to young investigators.
Meeting Organizer: Roger Bouillon – IBMS Immediate past-president
Scientific Program Committee
Representing Young Investigators
Representing Senior Investigators